thiophenes has been researched along with Anti-Phospholipid Antibody Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arachchillage, DJ; Cohen, H | 1 |
| Rodgers, GM; Win, K | 1 |
| Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE | 1 |
| Bachmeyer, C; Elalamy, I | 1 |
| Augustin, A; Auzary, C; Cheze, S; Darnige, L; de Boysson, H; Geffray, L; Jeanjean, C; Joalland, F; Johnson, A | 1 |
| Butler, J; Gan, E; Kaplan, Z; Malan, E; Merriman, E; Tran, H | 1 |
| de Groot, PG; de Laat, B; Kamphuisen, PW; Meijers, JC; van Os, GM | 1 |
1 review(s) available for thiophenes and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Use of new oral anticoagulants in antiphospholipid syndrome.
Topics: Administration, Oral; Adult; Animals; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Breast Feeding; Clinical Trials, Phase III as Topic; Contraindications; Dabigatran; Drug Monitoring; Female; Humans; Infant, Newborn; Maternal Exposure; Morpholines; Pregnancy; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes | 2013 |
1 trial(s) available for thiophenes and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Rivaroxaban and false positive lupus anticoagulant testing.
Topics: Anticoagulants; Antiphospholipid Syndrome; Blood Coagulation; Blood Coagulation Tests; False Positive Reactions; Humans; Lupus Coagulation Inhibitor; Morpholines; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin | 2011 |
5 other study(ies) available for thiophenes and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome.
Topics: Administration, Oral; Adult; Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2014 |
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin | 2014 |
Rivaroxaban as an effective treatment for recurrent superficial thrombophlebitis related to primary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Factor Xa Inhibitors; Female; Humans; Morpholines; Rivaroxaban; Thiophenes; Thrombophlebitis; Treatment Outcome | 2014 |
[Seronegative antiphospholipid syndrome, catastrophic syndrome, new anticoagulants: learning from a difficult case report].
Topics: Adolescent; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Disseminated Intravascular Coagulation; Factor Xa Inhibitors; Fondaparinux; Humans; Male; Morpholines; Polysaccharides; Rivaroxaban; Thiophenes | 2014 |
Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time.
Topics: Animals; Anticoagulants; Antiphospholipid Syndrome; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Endopeptidases; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Hydrolases; Predictive Value of Tests; Prothrombin; Rivaroxaban; Thiophenes; Time Factors | 2011 |